Skip to main content
. 2021 May 10;13(5):684. doi: 10.3390/pharmaceutics13050684
ADRs Adverse drug reactions
BC Breast cancer
EMA European Medicine Agency
FDA Food and Drug Administration
HER2 Human epidermal growth factor receptor-2
IV Intravenous
MedDRA Medical Dictionary for Regulatory Activities
SC Subcutaneous
WHO World Health Organization